Sign in

CIK 0001439725

  • Non-accelerated filer
  • Smaller reporting company

BIODESIX INC

Sign in to watch
Ticker
BDSX
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203986492
Phone
+1 303-417-0500
Business address
919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
  1. 4 Open-market buy Director bought 142,045 shares at $7.04 ($999,997)
  2. 4 Open-market buy Director bought 18,373 shares at an average $6.06 ($111,425)
  3. 4 Open-market buy Director bought 3,488,372 shares at $0.43 ($1,500,000)
  4. 4 Open-market sale CFO, Sec'y & Treasurer sold 988 shares at $0.42 ($411)
  5. 4 Open-market sale President & CEO sold 3,772 shares at $0.42 ($1,570)
  6. 4 Open-market sale Chief Commercial Officer sold 476 shares at $0.42 ($198)
  7. 4 Open-market sale Chief Development Officer sold 442 shares at $0.42 ($184)
  8. 4 Open-market sale Chief Accounting Officer sold 228 shares at $0.42 ($95)
  9. 4 Exercise or conversion Director acquired 22,874 shares (option exercise)
  10. 4 Exercise or conversion Director acquired 26,368 shares (option exercise)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market buy Director bought 4,723,239 shares at an average $0.28 ($1,316,624)
  18. 4 Open-market sale Chief Accounting Officer sold 224 shares at an average $0.36 ($80)
  19. 4 Open-market sale Chief Development Officer sold 445 shares at an average $0.36 ($158)
  20. 4 Open-market sale Chief Commercial Officer sold 477 shares at an average $0.36 ($170)

Page 3 of 17 · 336 filings